Skip to content

Retrospective Observational Cohort Study of SYMBOL CUP DM 2

Etude de Cohorte Observationnelle Rétrospective SYMBOL CUP 2

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04209426
Acronym
SYMCOR-2
Enrollment
20
Registered
2019-12-24
Start date
2015-03-18
Completion date
2018-08-14
Last updated
2025-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Total Hip Arthroplasty, Revision Total Hip Arthroplasty

Keywords

total hip arthroplasty, complex, revision, hemispherical dual-mobility acetabular cup, safety, efficacy, implant survival, prosthetic dislocation

Brief summary

This is a single-center retrospective observational cohort study of consecutively operated patients who underwent total hip arthroplasty (THA) with a SYMBOL CUP DMR HA or a SYMBOL CUP DM CEM hemispherical dual mobility acetabular implant. The purpose of this study is to estimate the safety and efficacy of those two implants at two-year follow-up.

Detailed description

Description according to PICOS (Patient, Intervention, Comparator, Outcomes, Study design) framework: Patients: \- Adult men and women requiring a total hip arthroplasty Intervention: \- THA with SYMBOL CUP DMR HA or SYMBOL CUP DM CEM hemispherical dual mobility acetabular implants. Comparator: None Outcomes: * Safety 1: Implant survival over 2-year follow-up. * Safety 2: All adverse events, with focus on implant dislocation, infections, revision surgery * Efficacy 1: Harris Hip Score (HHS) at baseline and 1-year follow-up. * Efficacy 2: Modified HHS (mHHS) consisting of pain + functional subscores at baseline, 1-year and 2-year follow-ups. * Efficacy 2: Devane score at baseline, 1-year and 2-year follow-ups. * Efficacy 3: Charnley classification at baseline, 1-year and 2-year followups. Study design: * single-center retrospective observational cohort study of consecutively operated patients who underwent total hip arthroplasty 2 years prior to study start. * Prospective 2-year follow-up letter and phone questionnaire.

Interventions

DEVICETHA with SYMBOL CUP DMR HA
DEVICETHA with SYMBOL CUP DM CEM

Sponsors

Dedienne Sante S.A.S.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All patients with total hip implant using hemispheric dual-mobility SYMBOL CUP DMR HA or SYMBOL CUP DM CEM * Operation performed by the primary investigator * Delay between index operation and March 1 2018 has reached 2 years

Exclusion criteria

* patient refusal to participate in the study * minors (age \< 18 years) * patients under guardianship

Design outcomes

Primary

MeasureTime frameDescription
Implant Survival: Acetabular Cup Survival at 2-year Follow-up2 years as of index operationThis is a the ratio of the number of patient joints surviving with the acetabular prosthesis in position at a given follow-up time (numerator) over the initial number of those joints from the date they received the acetabular prosthesis (denominator). The cumulative ratio is recalculated at each event using the Kaplan-Meier method from the date of each joint index operation through the date of each participant's death or prosthetic removal surgery or loss-to-follow-up or last assessment alive with the acetabular prosthesis in place. The longest duration between the index operation and the final assessment is 2 years.

Secondary

MeasureTime frameDescription
Number of Patients With One or Several Post-operative Adverse Events and Count of Each Serious Adverse Event and Aggregate Count of Adverse Events2 years as of index operationAll serious post-operative adverse events are taken into account including implant dislocation, infections, revision surgery.
Harris Hip Score (HHS) at Baseline and 1-year Follow-up1 year as of index operationHarris Hip Score (HHS) is measured at each assessment in each patient. HHS is a physician-completed instrument that consists of subscales for pain severity (1 item, 0-44 points), function (7 items, 0-47 points), absence of deformity (1 item, 0-4 points), and range of motion (2 items, 0-5 points). Scores range from 0 (worse disability) to 100 (less disability). The mean and confidence interval of the score is measured at each assessment as well as for the within-patient difference between assessments
The Modified Harris Hip Score (Modified HHS) at Baseline, 1-year and 2-year Follow-up2 years as of index operationThe modified Harris Hip Score (modified HHS) is the sum of pain subscore and functional subscore of the Harris Hip Score. It consists of subscales for pain severity (1 item, 0-44 points), function (7 items, 0-47 points). Scores range from 0 (worse disability) to 91 (less disability)The score is measured at each assessment in each patient. The mean and confidence interval of the score is measured at each assessment as well as for the within-patient difference between assessments

Countries

France

Participant flow

Participants by arm

ArmCount
HMB-DMR-HA
Total hip arthroplasty with hemispherical metal-back dual-mobility acetabular cup with tripod fixation consisting of a hydroxyapatite-coated outer surface as well as two pegs and one screw. THA with SYMBOL CUP DMR HA
15
HMB-DM-CEM
Total hip arthroplasty with hemispherical metal-back dual-mobility acetabular cup with tripod fixation consisting of a bare metal outer surface to be covered with bone-compatible cement. THA with SYMBOL CUP DM CEM
5
Total20

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up32

Baseline characteristics

CharacteristicHMB-DMR-HAHMB-DM-CEMTotal
Age, Continuous77.3 years
STANDARD_DEVIATION 33.4
77.6 years
STANDARD_DEVIATION 6.7
77.4 years
STANDARD_DEVIATION 26.7
BMI24.4 Kg/m2
STANDARD_DEVIATION 4.8
25.8 Kg/m2
STANDARD_DEVIATION 2.4
24.8 Kg/m2
STANDARD_DEVIATION 4.2
Operated side
Left
5 Participants3 Participants8 Participants
Operated side
Right
10 Participants2 Participants12 Participants
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
France
15 participants5 participants20 participants
Sex: Female, Male
Female
9 Participants3 Participants12 Participants
Sex: Female, Male
Male
6 Participants2 Participants8 Participants
Type of surgery
rTHA
10 Participants5 Participants15 Participants
Type of surgery
THA
5 Participants0 Participants5 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
3 / 150 / 5
other
Total, other adverse events
0 / 150 / 5
serious
Total, serious adverse events
7 / 150 / 5

Outcome results

Primary

Implant Survival: Acetabular Cup Survival at 2-year Follow-up

This is a the ratio of the number of patient joints surviving with the acetabular prosthesis in position at a given follow-up time (numerator) over the initial number of those joints from the date they received the acetabular prosthesis (denominator). The cumulative ratio is recalculated at each event using the Kaplan-Meier method from the date of each joint index operation through the date of each participant's death or prosthetic removal surgery or loss-to-follow-up or last assessment alive with the acetabular prosthesis in place. The longest duration between the index operation and the final assessment is 2 years.

Time frame: 2 years as of index operation

ArmMeasureValue (NUMBER)
HMB-DMR-HAImplant Survival: Acetabular Cup Survival at 2-year Follow-up94.7 percentage of implants survival
HMB-DM-CEMImplant Survival: Acetabular Cup Survival at 2-year Follow-up100 percentage of implants survival
Secondary

Harris Hip Score (HHS) at Baseline and 1-year Follow-up

Harris Hip Score (HHS) is measured at each assessment in each patient. HHS is a physician-completed instrument that consists of subscales for pain severity (1 item, 0-44 points), function (7 items, 0-47 points), absence of deformity (1 item, 0-4 points), and range of motion (2 items, 0-5 points). Scores range from 0 (worse disability) to 100 (less disability). The mean and confidence interval of the score is measured at each assessment as well as for the within-patient difference between assessments

Time frame: 1 year as of index operation

Population: Number at stake at 1 year take into account the following events (death, lost to follow-up and revisions)

ArmMeasureGroupValue (MEDIAN)Dispersion
HMB-DMR-HAHarris Hip Score (HHS) at Baseline and 1-year Follow-upHHS preoperative34 score on a scaleStandard Deviation 37.7
HMB-DMR-HAHarris Hip Score (HHS) at Baseline and 1-year Follow-upHHS 1-year89 score on a scaleStandard Deviation 24
HMB-DM-CEMHarris Hip Score (HHS) at Baseline and 1-year Follow-upHHS preoperative58 score on a scaleStandard Deviation 13.8
HMB-DM-CEMHarris Hip Score (HHS) at Baseline and 1-year Follow-upHHS 1-year86 score on a scaleStandard Deviation 34.2
Secondary

Number of Patients With One or Several Post-operative Adverse Events and Count of Each Serious Adverse Event and Aggregate Count of Adverse Events

All serious post-operative adverse events are taken into account including implant dislocation, infections, revision surgery.

Time frame: 2 years as of index operation

ArmMeasureValue (NUMBER)
HMB-DMR-HANumber of Patients With One or Several Post-operative Adverse Events and Count of Each Serious Adverse Event and Aggregate Count of Adverse Events10 participants
HMB-DM-CEMNumber of Patients With One or Several Post-operative Adverse Events and Count of Each Serious Adverse Event and Aggregate Count of Adverse Events0 participants
Secondary

The Modified Harris Hip Score (Modified HHS) at Baseline, 1-year and 2-year Follow-up

The modified Harris Hip Score (modified HHS) is the sum of pain subscore and functional subscore of the Harris Hip Score. It consists of subscales for pain severity (1 item, 0-44 points), function (7 items, 0-47 points). Scores range from 0 (worse disability) to 91 (less disability)The score is measured at each assessment in each patient. The mean and confidence interval of the score is measured at each assessment as well as for the within-patient difference between assessments

Time frame: 2 years as of index operation

Population: Number at stake at 1 year or 2-years take into account the following events (death, lost to follow-up and revisions)

ArmMeasureGroupValue (MEDIAN)Dispersion
HMB-DMR-HAThe Modified Harris Hip Score (Modified HHS) at Baseline, 1-year and 2-year Follow-upmHHS preoperative29 score on a scaleStandard Deviation 21.5
HMB-DMR-HAThe Modified Harris Hip Score (Modified HHS) at Baseline, 1-year and 2-year Follow-upmHHS 1-year80 score on a scaleStandard Deviation 22.5
HMB-DMR-HAThe Modified Harris Hip Score (Modified HHS) at Baseline, 1-year and 2-year Follow-upmHHS 2-year87 score on a scaleStandard Deviation 11.3
HMB-DM-CEMThe Modified Harris Hip Score (Modified HHS) at Baseline, 1-year and 2-year Follow-upmHHS preoperative49 score on a scaleStandard Deviation 13.4
HMB-DM-CEMThe Modified Harris Hip Score (Modified HHS) at Baseline, 1-year and 2-year Follow-upmHHS 1-year77 score on a scaleStandard Deviation 34.2
HMB-DM-CEMThe Modified Harris Hip Score (Modified HHS) at Baseline, 1-year and 2-year Follow-upmHHS 2-year80 score on a scaleStandard Deviation 10

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026